The Lancet Commission on medicine, Nazism, and the Holocaust: historical evidence, implications for today, teaching for tomorrow
By Herwig Czech et al.,
The Lancet
| 11. 08. 2023
Executive Summary
The Holocaust, the systematic, state-sponsored persecution and murder of 6 million Jews by the National Socialist (Nazi) regime and its collaborators, is arguably the most extreme instance of crimes against humanity and genocide in history. During its reign of terror, the Nazi regime committed innumerable acts of violence against Jews, Sinti and Roma, people with disabilities or psychiatric illnesses, political prisoners, prisoners of war, and others. A distinctive and disturbing feature of these atrocities is the important role that health professionals played in formulating, supporting, and implementing inhumane and often genocidal policies. After World War 2, these crimes were important factors that contributed to the establishment of contemporary health professional ethics. Learning about, and reflecting upon, this history can have various benefits for learners and practitioners of health sciences, and the patients and communities they serve. Health sciences curriculums, however, rarely cover this topic. This is why Richard Horton, The Lancet's Editor-in-Chief, convened the Lancet Commission on Medicine, Nazism, and the Holocaust.
Nearly 80 years after the defeat of Nazi Germany and the end of World War...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...